Quidel | QDEL - Net Income


Quidel reported $-733M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Agilent USD 434M 98M Sep/2025
Avanos Medical USD -1.4M 75.4M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Bruker USD -62.4M 70M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Illumina USD 150M 85M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Mettler Toledo International USD 217.49M 15.14M Sep/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Neogen USD -15.92M 52.26M Sep/2025
Quidel USD -733M 477.6M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
STAAR Surgical USD 8.88M 25.7M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Waters USD 148.92M 1.81M Sep/2025